Emily Y. Chew
NEW ORLEANS — An implant with ciliary neurotrophic factor has a beneficial effect and reduces the progressive loss of photoreceptors compared with untreated eyes, Emily Y. Chew, MD, said at Retina Subspecialty Day preceding the American Academy of Ophthalmology meeting, where she discussed results of the phase 2 trial of ciliary neurotrophic factor for macular telangiectasia.
Macular telangiectasia is a neurodegenerative problem, Chew said, and neurotrophic factors have been shown in animal models to slow the loss of photoreceptor cell death.
“We’ve had an animal
Uncategorized